chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a 27 year old female consumer with no pertinent medical history and no known allergies, who on 02-MAR-2007 was vaccinated with the first dose of Gardasil (lot # not provided). There was no concomitant medication. At some time in March 2007, she unknowingly became pregnant (date of LMP and estimated date of delivery not provided). On 07-MAY-2007, still unaware that she was pregnant, she was vaccinated with the second dose of Gardasil (lot # not provided). On 09-MAY-2007 she had surgery for an ectopic pregnancy, and was hospitalized for one day. Subsequently, the patient recovered from the events (duration not specified). No further details were provided. Additional information has been requested.
Information has been received from a healthcare worker referring to multiple unspecified patients of unknown age and gender. On unknown dates the patients were vaccinated with improperly stored VAQTA lot # K012457, expiration date: 06-APR-2017; lot # K012457, expiration date: 04-JUN-2017, (dose, dose #, route and application site were not reported). No adverse effects reported. This is one of several reports received from the same source. Additional information has been requested.
Within 15 minutes I became a little lightheaded/ ?off?.  I went home, rested and it resolved on its own:
Suspected vaccination failure; Shingles; This case was reported by a pharmacist via call center representative and described the occurrence of vaccination failure in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) (batch number 9LG54, expiry date 25th September 2021) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On 7th June 2019, the patient received the 2nd dose of Shingrix. On 21st July 2019, less than a year after receiving Shingrix and 44 days after receiving Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingrix and Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The pharmacist reported that patient developed Shingles on 21st July 2019, after receiving 2nd dose of Shingrix on 7th June 2019. This case was considered as suspected vaccination failure since the details regarding laboratory confirmation of herpes zoster were unknown at the time of reporting. The reporter was consented to follow up.
Patient received the Moderna BOOSTER vaccine earlier than the recommended interval of six months.  Patient completed primary series with Moderna, second dose was administered on 24 June 2021
AT 14:40 LPN notified by patient that she had spoken with co worker and believed she was having an allergic reaction R/T bumps on face and arms.
Sore arm starting around 8 pm, and quite tired the following day.  After a 2.5 hr nap, I was feeling much better
Vaccination  at 0830 am, reactions started at @ 0930 pm while at work, Worked till 0400 am. When I left work my feet felt like they were frostbitten, had chills and temp of 99.9. Went home took 2 Extra Strength Tylenol, went to bed with 100.8 temp. Got up the night of the 16th, chills were gone temp was 101.1. Took more Tylenol drank some fluids tried to eat but couldn't . Went back to bed 3 hrs later temp down to 99.9. got up today at 1130am fill fine ate and drank some, temp now is 99.5 but I fill fine.
pt recvd 1st dose of Engerix-B w/o incident; on the evening of 2nd dose pt devel loose stools & stomach ache which lasted 4 days;
Day of vaccine: fever, chills exhausted, headache, nausea and vomiting. Day after vaccine: exhausted, headache, body aches and some type of seizure. Days 2-5: body aches, headache. Saw primary medical provider and awaiting appointment with neurologist
Patient was given booster dose nearly a month too soon.  Patient was given second dose out of state on 10/11/21 according to patient.  Booster was then administered on 02/01/22.  Booster should have been administered five months after second dose since patient is not immunocompromised.  Patient is very hard to get a hold of and hasn't been reached yet to inform him that his booster was administered about a month too soon.  Patient was reached on 04/08/22 and provided missing second dose information to LPN and sounded in good spirits but was unable to talk for long due to being out of town and busy at the moment.  Attempted to call patient again today and no answer.  Unable to leave voicemail because patient's voice mailbox has not been setup.  Will continue to attempt to contact patient to notify him of situation and suggest he contact his PCP for examination.  If patient isn't reached soon by phone a letter will be mailed to his address listed on file.
-full arm swelling, underarm as well -shooting pain down arm -could not lift arm -lymph node involvement -H/A, dizziness, nausea
Pt received vaccines on 4/5/00. On 4/7/00 the parent contacted the health department with notification of symptom of induration, swelling, itching, no fever. On 4/14/00 the parent called and said the child was seen by MD who called this a TD vaccine reaction. The MD prescribed Keflex. Symptoms still persist.
Patient said she felt faint and then passed out. She was passed out for less than 1 minute. Blood pressure and pulse were taken and were within normal limits. Patient recovered quickly and was taken to her physician by her parents as they wanted her to be checked out.
Vertigo; This is a spontaneous report from a contactable consumer (patient). A 67-year-old male patient received the second dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, lot number: EN6198, expiry date unknown), via an unspecified route of administration, administered in the right arm on 27Feb2021 as a single dose for COVID-19 immunization.  The patient's medical history was not reported. The patient had no known allergies. The patient did not have COVID prior to the vaccination. There were no concomitant medications. The patient did not receive any other vaccine in four weeks and did not have other medications in four weeks. The patient received the first dose of BNT162B2 (lot number: EN6198) on 06Feb2021 at 02:45 PM on the right arm for COVID-19 immunization. It was reported that within 5-7 days after the last vaccination, on 08Mar2021 at 13:00, the patient developed vertigo. The patient ended up in the hospital twice before anyone was able to diagnose what was wrong with him. The patient was hospitalized on an unspecified date for 5 days. The patient did not receive treatment for the event. The patient was still having issues to this day. The outcome of the event was not recovered. The patient had a nasal swab COVID test on 22Mar2021 with a negative result.
This spontaneous report as received from a 75 year old male patient with bladder cancer, erythrocytosis, PERCOCET and penicillin allergy, lung cancer and prostate cancer refers to himself. On 19-Oct-2014 the patient was vaccinated with PNEUMOVAX 23 with injection route (dose, dose# and lot# unknown). Concomitant therapies included BENICAR, KEPPRA, SYNTHROID, allopurinol and simvastatin (manufacturer unknown). On 19-OCT-2014, the patient experienced muscle pain and shoulder joint pain after received PNEUMOVAX 23. The patient did not seek medical attention. There was no treatment given to the events. No labs performed. The outcome of the events was reported as not recovered/not resolved. Additional information has been requested.
7x6cm area erythema, warm, tender, slightly hard, Left deltoid. 2 days s/p immunization with DTap, flu IM and polio SC in left arm.
Fever, tired, and stomach ache.  Vomited at 7:30 PM.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  An 82-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 08Aug2022 at 13:00 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 82 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Chronic kidney disease" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Dec2022, outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19 which included received Paxlovid from 14Dec2022 to 18Dec2022.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Sore thro; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (Sore throat) and FATIGUE (Fatigue) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.   In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced OROPHARYNGEAL PAIN (Sore throat) and FATIGUE (Fatigue). At the time of the report, OROPHARYNGEAL PAIN (Sore throat) and FATIGUE (Fatigue) had resolved.            The patient had fatigue but had come out of his a little bit quicker than she did. He had a sore throat for a couple of days then it went away. He felt better one day and when he got up to do something he would feel worse and have to sit back down. He was better.  No Concomitant medications were reported. No treatment medications were reported.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
NO ADVERSE REACTION REPORTED. A PFIZER VACCINE WAS ADMISNISTERED TO A PATIENT AFTER BUD OF 7/22/22. PATIENT RECIEVED A PFIZER BOOSTER SHOT 2 DAYS AFTER BUD. The medical/safety team at Pfizer WAS CONTACTED AND indicated THE DISCOVERING PHARMACIST they do have stability but not efficacy data on the adult Pfizer vaccine beyond 72 days when stored in a refrigerator. They recommended that our Private contacts the CDC and inquires about repeating doses for these patients. Speaking with the CDC employees, our Private was given the same information as above and referred to the immunization division at the Private. Our Private contacted the DOH but she was asked to confer with either Medical Doctor or the standing order physician. Our Private was able to interact with the latter, and she was given the guidance of re-vaccinating. In the context of the guidance from the standing order physician, the patient will need to repeat the dose. Regular schedules for series completion/booster doses will be observed if/when warranted.
sore arm; sore neck/ neck pain; sore throat; headache; nausea; vomiting (threw up twice); joint pain; could not move her arm for 6 days; This is a spontaneous report from a contactable consumer (patient) via Pfizer sponsored program. A female patient of an unspecified age received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number- UNKNOWN) via an unspecified route of administration on 15Apr2021 as single dose and had previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number-UNKNOWN) via an unspecified route of administration on 16Mar2021 as single dose for covid-19 immunization. Patient medical history included COVID from an unspecified date in Jan2021 and dizziness from an unspecified date in Jan2021 which went away after five days of first dose and concomitant medications were not reported. Patient did not get tested for COVID-19. Patient said after first dose of the covid-19 vaccine she had a really sore arm, her second dose was last Thursday (15Apr2021) had a sore arm, sore neck/neck pain, sore throat, headache and nausea that lasted over 5 days, vomiting (threw up twice) could not move her arm for 6 days and joint pain and stated she had symptoms for 6 days after the second dose. Caller asked is it usual to have symptoms for six days. Caller asked if you have antibodies from having covid, can you have a stronger response to the second dose and have more side effects. Caller stated a doctor on TV had covid and was sick for 6 to 7 days after his vaccine. She read an article from a provider  about people with Rh negative factor and O negative blood had very mild symptoms of covid-19 and would like to speak to someone, relayed PMI number and hours, she had to go but will call number given, caller disconnected, will fax AE. The outcome of the events was unknown.   Upon follow-up (21Apr2021): This is a follow up spontaneous report from a female contactable consumer. This female consumer (patient) reported.  Upon follow-up (23Apr2021): This is a follow up spontaneous report from a female contactable consumer. This female consumer (patient) reported that: Only adverse event present and no PQC present.  Upon follow-up (21Apr2021): This is a follow up spontaneous report from a female contactable consumer. This female consumer (patient) reported about relevant medical history which was captured above and in the relevant fields.    No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Severe headache, mild shortness of breath/cough, fever of 101.1F, muscle ache at injection site, chills
It caused my menstrual cycle to begin nearly 2 weeks early. I track my cycle. I am very regular. My menstrual cycle should have started 11/6/21.  The only other time this has ever happened was when I contracted Covid earlier this year.  I?m reporting this because I think it?s important to look at the fact that this is occurring and if it?s creating any long-term reproductive issues.  I was forced through my employer and the governor to get both vaccines even though I already had Covid and was ill for 3 weeks.  Requiring any shot but especially the second shot is more harmful than helpful. I believe the second shot is creating an overload to the system with harmful effects which is also backed by studies.
Pfizer COVID 19 Vaccine was administered to 12 patients after the beyond use date. Medical Associates Director of Clinical Services and Vaccine Coordinator are working with Agency to reconcile the errors and provide appropriate follow upto affected patients.
12/2/20, One day after administration of booster dose: moderate pain below injection site and on underside of left arm/armpit, swollen lymph node in left armpit, fever (approx. 100f), extreme lethargy, shortness of breath.  12/3/20, Two days after vaccination: Pain of left arm has increased and underarm is extremely sensitive to touch. Fever, lethargy, swollen lymph node in left armpit, and shortness of breath persist unchanged. Now experiencing mild to moderate nausea and occasional vomiting.
had 2 shot vaccines. GAVE me shingles/suspected vaccination failure; Shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine with an associated reaction of herpes zoster (on an unknown date, had 1 shot vaccine).   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   The reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.  Additional details were reported as follows: The case was reported by the patient. The age at vaccination was not reported. The patient had both the one shot and 2 shot vaccines, and they both gave him/her shingles. This case was considered as suspected vaccination failure as details regarding time to onset and laboratory confirmation were unknown at the time of reporting. No contact details were available.
This case was extracted from VAERS via QScan on 11 march 2009 (reference number 246564). A 49-year-old female received an intramuscular injection of FLUZONESV '2005-'2006 USP (lot number U1838AA) on 27 October 2005. Within a few minutes of vaccination, her throat became swollen. Two to three hours post-vaccination she complained of "water in my lungs". Four hours post-vaccination she developed coughing and wheezing, and her eyes became swollen and inflamed with discharge. She had a low-grade fever (99.9 degrees) and later developed chills and nausea. The following day she felt achy and cold, and treatment included an antihistamine. Outcome was not reported.
Redness/rash over majority of body. Onset morning after first dose. Lasted for approx 2 days with some minor itching/irritation.
No adverse event at all, but patient was 16 and the age limit of 18 for Moderna was not caught during registration and giving of the vaccine. patient received Moderna when should have received Pfizer.
Gave 2nd booster of Janssen (primary and 1st booster were Janssen); Misread that she was eligible for a 2nd booster but it had to be with a MRNA vaccine
Syncope event post vaccination. Patient revived by rph. EMS contacted. Patient was escorted by mother & EMS to car & went home. Patient's mother will call with follow-up. BP/Pulse/Blood sugar all normal per EMS.
pt recvd vax; exp swelling of the arm, redness, warmth, pain & soreness at inject site
Numbness and tingling in left arm and foot within 10 minutes of receiving the vaccine. Symptoms resolved after 15 minutes. At approximately 6 pm, symptoms returned. However, I felt numbness and tingling in my whole left-side. I took a Tylenol 3 hours later, which decreased the pain but did not relieve it completely. I went to bed. The next morning, I felt better. The numbness in the foot returned the evening of 8/26/2021. Two weeks after the second dose of 9/22/2021, numbness of the left foot returned and lasted about 5 days. I saw my new PCP for the first time for these symptoms. EMG scheduled for January 2022. Numbness of left foot returns off and on.
Site: Itching at Injection Site-Medium, Systemic: Allergic: Itch (specify: facial area, extremeties)-Medium, Systemic: Allergic: Rash (specify: facial area, extremeties)-Medium, Systemic: "just feel sick"-Medium, Additional Details: patient says she felt sick up to 6 days after the shot. and had rash and full body itching until say 28 after shot. advised patient not to get shot until the itching has resolved. patient states she her doctor is prescribing a cream for her for the body rashes
About 10 minutes after giving patient an MMRV, the site was red and swelling.  About 15 minutes after MMRV given small red spots appeared on trunk. No shortness of breath or resp. distress noted.  Tylenol recommended for discomfort.  LPN
Initial report received on 03 May 2013 from the Investigator participating in a post-marketing study under the reference number M5A16. A case of pertussis disease in an 11 month-old female subject (initials not collected) was identified by the investigator based on review of data from the Electronic Disease Surveillance (EDSS) electronic database. The subject's medical history was not reported. The subject had received three doses of PENTACEL: dose one, lot number C4193AA on 21 June 2012; dose two, lot number C4259AA on 21 August 2012; and dose three, lot number C4299AA, on 22 October 2012 (routes and sites of administration not reported). The subject developed cold-like symptoms on 11 March 2013, approximately four months after the last dose. On 11 March 2013, the subject developed both a cough and paroxysmal cough without a whoop. The subject also experienced posttussive vomiting and sleep disturbance. Laboratory testing included a positive PCR on 25 April 2013. Chest x-ray findings were negative (unspecified date). Corrective treatments consisted of Azithromycin starting on 25 April 2013 for five days. The subject was not hospitalized. At the time of final contact on 26 April 2013, the subject's cough was still persisting. The duration of the cough was reported at that time as 46 days. The subject's outcome was not recovered. Investigator causality assessment is not required as per protocol. This is one case out of a cumulative total of 197 cases solicited from the Electronic Disease Surveillance System (EDSS) during the surveillance period from 01 January 2010 to 03 May 2013. These 197 cases represent children who received three or more doses of sanofi pasteur vaccine; cases of pertussis disease in children who received DTaP combination vaccines from other manufacturers are not reported as per study protocol. Documents held by sender: None.
Inflammatory arthritis with joint stiffness and swelling since January 2022, with evidence of inflammatory arthritis on recent exam, worsening over the past 3 months.
This is a spontaneous report from a contactable consumer, the patient. A 32-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 17Apr2021 at 15:30 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received unspecified medication within two weeks of vaccination. On 17Apr2021 at 20:30, the patient experienced headache, nausea, stomach cramping, diarrhea, weakness, easily fatigued and tired. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache, nausea, stomach cramping, diarrhea, weakness, easily fatigued and tired was not recovered at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
This spontaneous report as received from a registered nurse refers to a 4 week old patient of unknown gender. Patient's concurrent conditions and relevant medical history was not reported. On 23-OCT-2014, the patient was vaccinated with first dose of RECOMBIVAX HB (dose, frequency, lot number and route unspecified). On 25-NOV-2014 the patient was vaccinated with second dose of expired RECOMBIVAX HB (lot number: H010380 with expiry date of 18-NOV-2014) (dose and route unspecified). Concomitant medications were not reported. No adverse effects were reported. The outcome of the events was unknown. The causality of the events with RECOMBIVAX HB was not reported. Additional information has been requested.
Pfizer vaccines on 1/28, 2/18/21 Tested positive for COVID by PCR on 12/13/21 Admitted to hospital on 12/13/21 d/t femoral neck fracture s/p fall. Asymptomatic for COVID 19 at time case was reported, incidental finding upon hospital admission.